- Home
- SERV vs SION Comparison
SERV vs SION Comparison
Compare SERV & SION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERV
- SION
- Stock Information
- Founded
- SERV 2017
- SION 2019
- Country
- SERV United States
- SION United States
- Employees
- SERV N/A
- SION N/A
- Industry
- SERV Industrial Specialties
- SION
- Sector
- SERV Consumer Discretionary
- SION
- Exchange
- SERV Nasdaq
- SION NYSE
- Market Cap
- SERV 682.1M
- SION 564.4M
- IPO Year
- SERV N/A
- SION 2025
- Fundamental
- Price
- SERV $11.24
- SION $14.83
- Analyst Decision
- SERV Strong Buy
- SION Strong Buy
- Analyst Count
- SERV 4
- SION 1
- Target Price
- SERV $17.00
- SION $32.00
- AVG Volume (30 Days)
- SERV 5.7M
- SION 124.8K
- Earning Date
- SERV 08-12-2025
- SION 08-25-2025
- Dividend Yield
- SERV N/A
- SION N/A
- EPS Growth
- SERV N/A
- SION N/A
- EPS
- SERV N/A
- SION N/A
- Revenue
- SERV $1,306,237.00
- SION N/A
- Revenue This Year
- SERV $298.51
- SION N/A
- Revenue Next Year
- SERV $586.63
- SION N/A
- P/E Ratio
- SERV N/A
- SION N/A
- Revenue Growth
- SERV 17.26
- SION N/A
- 52 Week Low
- SERV $1.82
- SION $7.26
- 52 Week High
- SERV $24.35
- SION $25.19
- Technical
- Relative Strength Index (RSI)
- SERV N/A
- SION N/A
- Support Level
- SERV N/A
- SION N/A
- Resistance Level
- SERV N/A
- SION N/A
- Average True Range (ATR)
- SERV 0.00
- SION 0.00
- MACD
- SERV 0.00
- SION 0.00
- Stochastic Oscillator
- SERV 0.00
- SION 0.00
About SERV Serve Robotics Inc. Common Stock
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an AI-robotics mobility platform, with last-mile delivery in cities as its first application.
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.